doc_id	mention	start	end
993342	deficiency of the second component of complement	105	153
993342	deficiency of the second component of complement	257	305
993342	deficiency of the second component of complement (C2)	257	310
993342	connective tissue disorders	352	379
993342	C2 deficiency	453	466
993342	C2 deficiency	512	525
993342	C2 deficiency	603	616
993342	C2 deficiency	734	747
993342	C2 deficiency	1337	1350
993342	C2 deficiency	1448	1461
993342	C2 deficiency	1489	1502
993342	C2 deficiency	1666	1679
993342	C2 deficiency gene	603	621
993342	C2 deficiency gene	1666	1684
932197	hereditary deficiency of the fifth component of complement	156	214
932197	C5	216	218
932197	C5	389	391
932197	C5	697	699
932197	C5	760	762
932197	C5	827	829
932197	C5	983	985
932197	C5	1055	1057
932197	C5	1069	1071
932197	C5	1116	1118
932197	C5	1132	1134
932197	C5	1198	1200
932197	C5	1257	1259
932197	C5	1426	1428
932197	C5	1517	1519
932197	C5	1540	1542
932197	C5	1701	1703
932197	C5	1916	1918
932197	systemic lupus erythematosus	279	307
932197	lupus	288	293
932197	lupus	528	533
932197	C1	539	541
932197	C4	543	545
932197	C2	547	549
932197	C3	555	557
932197	underlying disease	626	644
932197	C5 deficiency	983	996
932197	C5-deficient	1055	1067
932197	C5D	1069	1072
932197	C5D	1257	1260
932197	C5D	1426	1429
932197	C5D	1916	1919
932197	C5D serum	1257	1266
932197	C5D serum	1426	1435
932197	membranous glomerulonephritis	1619	1648
932197	vasculitis	1650	1660
932197	arthritis	1666	1675
932197	bacterial infections	1769	1789
932197	corticosteroid therapy	1855	1877
932197	C5D state	1916	1925
932197	pyogenic infection	2034	2052
932197	beta hexosaminidase A	-1	-1
932197	deficiency of this enzyme	-1	-1
932197	beta hexosaminidase A (hex A)	-1	-1
932197	deficiency of hex A activity	-1	-1
932197	Tay-Sachs disease	-1	-1
932197	TSD	-1	-1
932197	hex A	-1	-1
932197	hex A deficiency	-1	-1
932197	deficiency of the type described	-1	-1
9288106	ataxia-telangiectasia	40	61
9288106	T-cell leukaemia	81	97
9288106	T-cell leukaemia	524	540
9288106	Ataxia-telangiectasia (A-T)	99	126
9288106	A-T	122	125
9288106	A-T	304	307
9288106	A-T	549	552
9288106	A-T	663	666
9288106	A-T	1070	1073
9288106	cancer	235	241
9288106	lymphoid neoplasias	254	273
9288106	chromosomal instability	351	374
9288106	sporadic T-cell prolymphocytic leukaemia	419	459
9288106	T-PLL	461	466
9288106	T-PLL	606	611
9288106	T-PLL	1030	1035
9288106	T-PLL	1603	1608
9288106	T-PLL	1741	1746
9288106	malignancy	483	493
9288106	mature T-cell leukaemia	517	540
9288106	leukaemia	88	97
9288106	leukaemia	450	459
9288106	leukaemia	531	540
9288106	leukaemia	713	722
9288106	leukaemia	1212	1221
9288106	mutated T-PLL	1022	1035
9288106	tumour	389	395
9288106	tumour	1160	1166
9288106	tumour	1279	1285
9288106	tumour	1517	1523
9288106	tumour	1641	1647
9288106	B-cell non-Hodgkins lymphomas	1309	1338
9288106	B-NHL	1340	1345
9288106	B-NHL	1353	1358
9288106	loss-of-function mutations	1414	1440
9288106	mutated tumours	1509	1524
9288106	sporadic T-PLL	1594	1608
9288106	hereditary predisposition to T-PLL	1712	1746
9294109	Myotonic dystrophy protein kinase	0	33
9294109	Myotonic dystrophy	0	18
9294109	Myotonic dystrophy	114	132
9294109	DM	134	136
9294109	DM	262	264
9294109	DM	281	283
9294109	DM	398	400
9294109	DM	631	633
9294109	DM	681	683
9294109	DM	1228	1230
9294109	DM	1279	1281
9294109	muscular disorder	158	175
9294109	DM protein kinase	262	279
9294109	DMPK	281	285
9294109	DMPK	398	402
9294109	DMPK	631	635
9294109	DMPK	681	685
9294109	DMPK	1228	1232
9294109	DMPK	1279	1283
9294109	DMPK [-/-] knockout mice	631	655
9294109	DMPK [-/-] myotubes	681	700
9294109	mutant myotubes	859	874
9294109	DMPK absence	1228	1240
9311732	retinoblastoma	71	85
9311732	retinoblastoma	129	143
9311732	retinoblastoma	278	292
9311732	retinoblastoma	440	454
9311732	retinoblastoma	1839	1853
9311732	retinoblastoma	1939	1953
9311732	LOH (loss of constitutional heterozygosity)	-1	-1
9311732	hypermethylation	1211	1227
9311732	somatic mosaicism	1564	1581
9311732	bilateral retinoblastoma	1829	1853
9336417	ankylosing spondylitis	18	40
9336417	ankylosing spondylitis	199	221
9336417	ankylosing spondylitis (AS)	199	226
9336417	AS	223	225
9336417	AS	248	250
9336417	AS	808	810
9336417	AS	1512	1514
9336417	AS	1693	1695
9336417	disease	415	422
9336417	disease	863	870
9336417	disease	1055	1062
9336417	disease	1084	1091
9336417	disease	1131	1138
9336417	disease	1235	1242
9336417	disease	1272	1279
9336417	disease	1588	1595
9342365	early-onset breast cancer	-1	-1
9342365	ovarian cancer	174	188
9342365	tumor suppressor	241	257
9342365	tumor suppression	1403	1420
9358014	hereditary hemochromatosis (HH)	95	126
9358014	HH	123	125
9358014	HH	798	800
9358014	HH	945	947
9358014	cancer	1048	1054
9360520	Autosomal dominant neurohypophyseal diabetes insipidus	0	54
9360520	Autosomal dominant neurohypophyseal diabetes insipidus	131	185
9360520	Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI)	131	193
9360520	diabetes insipidus	36	54
9360520	diabetes insipidus	167	185
9360520	diabetes insipidus	453	471
9360520	ADNDI	187	192
9360520	ADNDI	587	592
9371490	prostate cancer	47	62
9371490	prostate cancer	387	402
9371490	prostate cancer	667	682
9371490	prostate cancer	1149	1164
9371490	prostate carcinoma	73	91
9371490	cancer	56	62
9371490	cancer	116	122
9371490	cancer	230	236
9371490	cancer	396	402
9371490	cancer	676	682
9371490	cancer	1158	1164
9371490	prostate tumors	710	725
9371490	tumors	719	725
9371490	tumors	1065	1071
9371490	10q23 loss of heterozygosity	973	1001
9371490	10q loss	1128	1136
9382108	Huntington disease	41	59
9382108	Huntington disease	94	112
9382108	Huntington disease (HD)	94	117
9382108	HD	114	116
9382108	HD	232	234
9382108	HD	426	428
9382108	risk reversal	823	836
9382108	risk reversal	980	993
9382108	risk reversals	823	837
9385378	mucopolysaccharidosis IVA	96	121
9385378	Mucopolysaccharidosis IVA	123	148
9385378	MPS IVA	150	157
9385378	MPS IVA	498	505
9385378	MPS IVA	772	779
9385378	lysosomal storage disorder	185	211
9391879	BRCA1 germline mutations	17	41
9391879	breast/ovarian cancer	55	76
9391879	breast/ovarian cancer	127	148
9391879	breast/ovarian cancer	835	856
9391879	BRCA1 gene	188	198
9391879	germline mutations	23	41
9391879	germline mutations	162	180
9391879	germline mutations	219	237
9391879	breast cancer	247	260
9391879	breast-ovarian cancer	281	302
9391879	frameshift mutation	332	351
9391879	nonsense mutation	357	374
9391879	splice site mutation	386	406
9391879	missense mutation	416	433
9391879	missense mutation	439	456
9391879	missense mutation	705	722
9391879	disease	534	541
9391879	disease	573	580
9391879	disease onset	573	586
9391879	causative mutations	616	635
9391879	susceptibility gene(s)	-1	-1
9391889	congenital myotonic dystrophy	25	54
9391889	congenital myotonic dystrophy	104	133
9391889	congenital myotonic dystrophy (DM)	104	138
9391889	mentally retarded	170	187
9391889	muscular weakness	212	229
9391889	respiratory and feeding difficulties	249	285
9391889	childhood onset DM	321	339
9391889	adult type of DM	367	383
9391889	congenital DM	462	475
9391889	congenital DM	558	571
9391889	congenital DM	746	759
9391889	congenital DM	946	959
9391889	congenital DM	1003	1016
9391889	adult onset DM	607	621
9391889	DM	135	137
9391889	DM	337	339
9391889	DM	381	383
9391889	DM	473	475
9391889	DM	569	571
9391889	DM	619	621
9391889	DM	757	759
9391889	DM	957	959
9391889	DM	1014	1016
9391889	DM	1065	1067
9400934	retinoblastoma	59	73
9400934	retinoblastoma	151	165
9400934	retinoblastoma	753	767
9420335	pancreatic cancers	254	272
9420335	Growth retardation	475	493
9420335	apoptosis	587	596
9420335	gastrulation defect	681	700
9420335	gastrulation defect	820	839
9420335	severe anterior truncations	915	942
9425228	melanoma	52	60
9425228	melanoma	208	216
9425228	melanoma	321	329
9425228	melanoma	958	966
9425228	melanoma	1010	1018
9425228	melanoma-predisposing gene	1010	1036
9425239	myotonic dystrophy	77	95
9425239	myotonic dystrophy	127	145
9425239	myotonic dystrophy	1053	1071
9425239	myotonic dystrophy (DM)	127	150
9425239	DM	147	149
9425239	DM	215	217
9425239	DM	293	295
9425239	DM	963	965
9425239	DM mutation	293	304
9425239	disease	644	651
9425239	symptoms	760	768
9427148	Aspartylglucosaminuria	0	22
9427148	Aspartylglucosaminuria	48	70
9427148	Aspartylglucosaminuria (AGU)	48	76
9427148	AGU	72	75
9427148	AGU	203	206
9427148	AGU	354	357
9427148	AGU	559	562
9427148	Aspartylglucosaminidase (AGA)	-1	-1
9427148	disorder	87	95
9427148	disorder	419	427
9427148	disease	624	631
9439660	ataxia-telangiectasia (ATM)	42	69
9439660	ataxia-telangiectasia (A-T)	152	179
9439660	autosomal recessive syndrome	236	264
9439660	radiosensitivity	99	115
9439660	radiosensitivity	332	348
9439660	radiosensitivity	520	536
9439660	radiosensitivity	1036	1052
9439660	malignancy	381	391
9439660	A-T	175	178
9439660	A-T	455	458
9439660	A-T	621	624
9439660	A-T	647	650
9439660	A-T	840	843
9439660	A-T	1092	1095
9439660	cancer	470	476
9439660	cancer	1221	1227
9439660	cancers	1221	1228
9439660	tumor	1301	1306
9443866	Ataxia-telangiectasia	0	21
9443866	diseases	197	205
9443866	breast cancer	215	228
9443866	ataxia-telangiectasia (A-T)	309	336
9443866	A-T	332	335
9443866	A-T	1236	1239
9448273	von Hippel-Lindau tumor suppressor gene	4	43
9448273	von Hippel-Lindau (VHL) tumor suppressor gene	123	168
9448273	VHL cancer syndrome	215	234
9448273	renal cell carcinomas (RCC)	267	294
9448273	RCC	290	293
9448273	RCC	343	346
9448273	RCC	738	741
9448273	RCC	851	854
9448273	cancer	219	225
9448273	cancer	571	577
9448273	cancer	742	748
9448273	RCC cancer	738	748
9448273	tumor	22	27
9448273	tumor	147	152
9448273	tumor	357	362
9448273	tumor	1200	1205
9448273	tumor	1304	1309
9448273	tumor suppressor	22	38
9448273	tumor suppressor	147	163
9448273	tumor suppressor	1304	1320
9450866	Piebaldism	0	10
9450866	deafness	16	24
9450866	deafness	171	179
9450866	deafness	431	439
9450866	deafness	514	522
9450866	piebaldism	122	132
9450866	piebaldism	464	474
9450866	piebaldism	584	594
9450866	piebaldism	675	685
9450866	congenital sensorineural deafness	146	179
9450866	auditory anomalies	330	348
9450866	Waardenburg syndrome	711	731
9457913	generalized atrophic benign epidermolysis bullosa	142	191
9457913	generalized atrophic benign epidermolysis bullosa	207	256
9457913	generalized atrophic benign epidermolysis bullosa	451	500
9457913	aberrant transcripts	48	68
9457913	aberrant transcripts	770	790
9457913	frameshift mutation	943	962
9457913	splice-site mutation	92	112
9457913	splice-site mutation	401	421
9457913	splice-site mutation	725	745
9457913	splice-site mutation	983	1003
9457913	splice-site mutation	1660	1680
9457913	premature termination codon	1364	1391
9457913	premature termination codon	1732	1759
9457913	premature termination codon	1783	1810
9457914	generalized atrophic benign epidermolysis bullosa	62	111
9457914	generalized atrophic benign epidermolysis bullosa	173	222
9457914	generalized atrophic benign epidermolysis bullosa	524	573
9457914	junctional epidermolysis bullosa	252	284
9457914	generalized blistering	291	313
9457914	nail dystrophy	315	329
9457914	patchy alopecia	331	346
9457914	dental abnormalities	352	372
9457914	Skin fragility	374	388
9463309	anhaptoglobinemia	46	63
9463309	anhaptoglobinemia	152	169
9463309	anhaptoglobinemia	456	473
9463309	anhaptoglobinemia	1746	1763
9463309	hypohaptoglobinemia	678	697
9463309	hypohaptoglobinemia	1871	1890
9463309	hypohaptoglobinemic	879	898
9463309	hypohaptoglobinemic	986	1005
9463314	ataxia-telangiectasia	32	53
9463314	ataxia-telangiectasia	220	241
9463314	leukemia	126	134
9463314	leukemia	1009	1017
9463314	lymphoma	136	144
9463314	lymphoma	1019	1027
9463314	lymphoma	1074	1082
9463314	breast cancer	150	163
9463314	breast cancer	613	626
9463314	ataxia-telangiectasia (A-T)	220	247
9463314	cerebellar degeneration	455	478
9463314	cerebellar degeneration	771	794
9463314	A-T phenotype	731	744
9463314	A-T	243	246
9463314	A-T	520	523
9463314	A-T	731	734
9463314	A-T	965	968
9463314	A-T	1254	1257
9463314	preleukemic T-cell proliferation	1029	1061
9463314	Hodgkin lymphoma	1066	1082
9463318	myotonic dystrophy	35	53
9463318	myotonic dystrophy	318	336
9463318	onset of the disease	950	970
9463318	congenital	975	985
9465039	hemochromatosis	4	19
9465039	hemochromatosis	196	211
9465039	hemochromatosis	1995	2010
9465039	hereditary hemochromatosis	185	211
9465039	hereditary hemochromatosis	1984	2010
9465301	Angelman syndrome	173	190
9465301	15q11-q13 deletions	209	228
9465301	chromosome 15 paternal uniparental disomy	232	273
9465301	mutation	892	900
9465301	imprinting	905	915
9467011	Cowden disease	53	67
9467011	Cowden disease	674	688
9467011	Bannayan-Zonana syndrome	72	96
9467011	hamartoma syndromes	102	121
9467011	hamartoma syndromes	653	672
9467011	PTEN mutation	136	149
9467011	PTEN mutation	866	879
9467011	PTEN mutation	882	895
9467011	PTEN mutation	1198	1211
9467011	PTEN mutation	1521	1534
9467011	PTEN mutation	2203	2216
9467011	PTEN mutation	2388	2401
9467011	human malignancy	348	364
9467011	breast	429	435
9467011	breast	2126	2132
9467011	breast	2233	2239
9467011	breast	2416	2422
9467011	breast	2697	2703
9467011	brain	437	442
9467011	prostate	444	452
9467011	kidney cancer	457	470
9467011	endometrial carcinomas	521	543
9467011	malignant melanoma	545	563
9467011	thyroid tumours	568	583
9467011	CD	690	692
9467011	CD	805	807
9467011	CD	931	933
9467011	CD	1215	1217
9467011	CD	1300	1302
9467011	CD	1799	1801
9467011	CD	1966	1968
9467011	CD	2109	2111
9467011	CD	2825	2827
9467011	Bannayan-Zonana	72	87
9467011	Bannayan-Zonana	710	725
9467011	BZS	727	730
9467011	BZS	827	830
9467011	BZS	1575	1578
9467011	BZS	1819	1822
9467011	BZS	1900	1903
9467011	Ruvalcaba-Riley-Smith syndrome	735	765
9467011	PTEN mutations	866	880
9467011	PTEN mutations	882	896
9467011	PTEN mutations	1521	1535
9467011	breast disease	2126	2140
9467011	breast disease	2416	2430
9467011	malignant breast disease	2406	2430
9472666	Complement component C6 deficiency	101	135
9472666	C6D	137	140
9472666	C6D	272	275
9472666	C6D	720	723
9472666	meningococcal meningitis	200	224
9472666	meningitis	214	224
9472666	meningitis	300	310
9472666	neisserial infection	320	340
9482572	aniridia	69	77
9482572	aniridia	295	303
9482572	Peters anomaly	120	134
9482572	congenital cataracts	141	161
9482572	autosomal dominant keratitis	168	196
9482572	isolated foveal hypoplasia	207	233
9497246	breast cancer	78	91
9497246	breast cancer	189	202
9497246	breast cancer	299	312
9497246	breast cancer	826	839
9497246	breast cancer	981	994
9497246	breast cancer	1616	1629
9497246	breast cancer	1863	1876
9497246	ovarian cancer	688	702
9497246	ovarian cancer	1736	1750
9497246	breast-ovarian cancer	681	702
9506545	autosomal dominant cerebellar ataxia type I	54	97
9506545	autosomal dominant cerebellar ataxias type I	259	303
9506545	spinocerebellar ataxias 1	304	329
9506545	SCA1	337	341
9506545	SCA1	416	420
9506545	SCA1	1081	1085
9506545	SCA1	1228	1232
9506545	SCA2	351	355
9506545	SCA2	537	541
9506545	SCA2	1098	1102
9506545	SCA2	1234	1238
9506545	SCA3/Machado-Joseph disease	369	396
9506545	SCA3	369	373
9506545	SCA3	816	820
9506545	SCA3	1133	1137
9506545	SCA3	1244	1248
9506545	diseases	1281	1289
9521325	idiopathic ventricular fibrillation	42	77
9521325	idiopathic ventricular fibrillation	328	363
9521325	IVF	365	368
9521325	IVF	391	394
9521325	IVF	604	607
9521325	IVF	640	643
9521325	IVF	954	957
9521325	IVF	1258	1261
9521325	sudden death	130	142
9521325	sudden death	552	564
9521325	cardiac rhythm disturbance	651	677
9521421	mucopolysaccharidosis IVA	27	52
9521421	MPS IVA	200	207
9521421	MPS IVA	476	483
9521421	MPS IVA	593	600
9521421	MPS IVA	1889	1896
9521421	severe clinical phenotype	508	533
9521421	severe	508	514
9521421	severe	690	696
9521421	severe	998	1004
9521421	intermediate	708	720
9521421	mild	157	161
9521421	mild	731	735
9521421	mild	921	925
9521421	mild	1260	1264
9521421	mild phenotype	157	171
9521421	mild phenotype	1260	1274
9521421	severe phenotype	998	1014
9529364	constitutional WT1 mutations	18	46
9529364	isolated diffuse mesangial sclerosis	65	101
9529364	Denys-Drash syndrome (DDS)	356	382
9529364	diffuse mesangial sclerosis (DMS)	387	420
9529364	pseudohermaphroditism	437	458
9529364	Wilms tumor (WT)	466	482
9529364	isolated DMS (IDMS)	675	694
9529364	DDS	378	381
9529364	DDS	502	505
9529364	DDS	704	707
9529364	DDS	996	999
9529364	urogenital abnormalities	720	744
9529364	WT	33	35
9529364	WT	227	229
9529364	WT	479	481
9529364	WT	752	754
9529364	WT	766	768
9529364	WT	883	885
9529364	WT	1013	1015
9529364	WT	1206	1208
9529364	IDMS	689	693
9529364	IDMS	834	838
9529364	IDMS	864	868
9529364	IDMS	953	957
9529364	IDMS	1058	1062
9529364	disease	1114	1121
9529364	DMS	416	419
9529364	DMS	684	687
9529364	DMS	690	693
9529364	DMS	835	838
9529364	DMS	865	868
9529364	DMS	954	957
9529364	DMS	1059	1062
9529364	DMS	1420	1423
9529364	DMS	1449	1452
9529364	sexual ambiguity	1569	1585
9536083	familial breast and ovarian cancer	188	222
9536083	breast/ovarian cancer	929	950
9546397	hereditary hemochromatosis	195	221
9546397	iron-overload disease	173	194
9554743	Wilson disease	111	125
9554743	Wilson disease	277	291
9554743	Wilson disease	748	762
9563950	myotonic dystrophy	61	79
9563950	Myotonic dystrophy (DM)	81	104
9563950	DM	101	103
9563950	DM	170	172
9563950	DM	192	194
9563950	DM	672	674
9563950	DM	858	860
9563950	CUG-binding protein (CUG-BP)	437	465
9563950	CUG-BP	458	464
9563950	CUG-BP	517	523
9563950	CUG-BP	823	829
9580132	familial neurohypophyseal diabetes insipidus	140	184
9580132	Familial neurohypophyseal diabetes insipidus (FNDI)	186	237
9580132	FNDI	232	236
9580132	FNDI	463	467
9580132	FNDI	1173	1177
9585583	Saethre-Chotzen syndrome	25	49
9585583	Saethre-Chotzen syndrome	131	155
9585583	Saethre-Chotzen syndrome	561	585
9585583	craniosynostosis	198	214
9585583	coronal synostosis	845	863
9585583	brachycephaly	865	878
9585583	low frontal hairline	880	900
9585583	facial asymmetry	902	918
9585583	ptosis	920	926
9585583	hypertelorism	928	941
9585583	broad great toes	943	959
9585583	clinodactyly	965	977
9585583	craniosynostotic condition	1197	1223
9585583	Saethre-Chotzen	25	40
9585583	Saethre-Chotzen	131	146
9585583	Saethre-Chotzen	561	576
9585583	Saethre-Chotzen	1232	1247
9585583	Crouzon	1249	1256
9585583	Pfeiffer syndromes	1262	1280
9585605	Angelman syndrome	30	47
9585605	Angelman syndrome	58	75
9585605	Angelman syndrome (AS)	58	80
9585605	UPD	177	180
9585605	AS	77	79
9585605	AS	402	404
9585605	AS	981	983
9585605	AS	1025	1027
9585605	AS	1067	1069
9585606	Hemochromatosis	96	111
9585606	hemochromatosis	4	19
9585606	hemochromatosis	231	246
9585606	hemochromatosis	473	488
9585611	attenuated adenomatous polyposis coli	35	72
9585611	attenuated adenomatous polyposis coli	140	177
9585611	attenuated adenomatous polyposis coli (AAPC)	140	184
9585611	familial adenomatous polyposis (FAP)	199	235
9585611	AAPC	179	183
9585611	AAPC	237	241
9585611	AAPC	428	432
9585611	AAPC	569	573
9585611	AAPC	1260	1264
9585611	AAPC	1438	1442
9585611	colorectal cancer	321	338
9585611	colorectal adenomas	899	918
9585611	colorectal adenomas	1305	1324
9585611	upper-gastrointestinal manifestations	984	1021
9585611	adenomas	291	299
9585611	adenomas	910	918
9585611	adenomas	1132	1140
9585611	adenomas	1316	1324
9585611	desmoid tumors	1367	1381
9585611	FAP	231	234
9585611	FAP	1631	1634
9590178	Wilms' tumor	0	12
9590178	Wilms tumor 1 (WT1)	146	165
9590178	male pseudohermaphroditism	538	564
9590178	Denys-Drash syndrome	568	588
9590178	sex-reversal	674	686
9590284	Prader-Willi syndrome	18	39
9590284	Prader-Willi syndrome	283	304
9590284	Prader-Willi syndrome (PWS)	283	310
9590284	PWS	306	309
9590284	PWS	373	376
9590284	PWS	546	549
9590284	PWS	617	620
9590284	PWS	754	757
9600235	ataxia-telangiectasia	47	68
9600235	ataxia-telangiectasia	298	319
9600235	A-T	165	168
9600235	A-T	321	324
9600235	A-T	401	404
9600235	A-T	555	558
9603435	subacute G(M2) gangliosidosis	124	153
9603435	Tay-Sachs disease (TSD)	285	308
9603435	G (M2) gangliosidosis	338	359
9603435	G (M2) gangliosidosis	737	758
9603435	subacute variant of G (M2) gangliosidosis	717	758
9603435	infantile disease-causing	828	853
9603435	infantile TSD	1460	1473
9603435	Hex A enzyme deficiency	1678	1701
9618166	Pendred syndrome	35	51
9618166	Pendred syndrome	53	69
9618166	Pendred syndrome	1189	1205
9618166	Pendred patients	893	909
9618170	X-linked dilated cardiomyopathy	77	108
9618170	X-linked dilated cardiomyopathy	110	141
9618170	XLDCM	143	148
9618170	XLDCM	422	427
9618170	XLDCM	508	513
9618170	XLDCM	659	664
9618170	XLDCM	1151	1156
9618170	dystrophinopathy	177	193
9618170	Duchenne muscular dystrophy	345	372
9618170	DMD	57	60
9618170	DMD	379	382
9618170	DMD	495	498
9618170	DMD	646	649
9618170	DMD	1079	1082
9620771	Severe early-onset obesity	0	26
9620771	adrenal insufficiency	28	49
9620771	adrenal insufficiency	1592	1613
9620771	red hair pigmentation	54	75
9620771	red hair pigmentation	1618	1639
9620771	isolated ACTH deficiency	389	413
9620771	ACTH deficiency	398	413
9620771	ACTH deficiency	1041	1056
9620771	human obesity	696	709
9620771	human obesity	815	828
9620771	obesity	19	26
9620771	obesity	702	709
9620771	obesity	821	828
9620771	obesity	1001	1008
9620771	obesity	1583	1590
9620771	early-onset obesity	7	26
9620771	early-onset obesity	1571	1590
9634518	Phenylalanine hydroxylase deficiency	-1	-1
9634518	Phenylketonuria (PKU)	177	198
9634518	Mild hyperphenylalaninemia (MHP)	-1	-1
9634518	PAH deficiency	413	427
9634518	PAH deficiency	1442	1456
9634518	Metabolic phenotype	-1	-1
9634518	Biochemical phenotype	-1	-1
9634518	Hyperphenylalaninemia	-1	-1
9668171	myotonic dystrophy (DM)	324	347
9668171	DM	267	269
9668171	DM	291	293
9668171	DM	344	346
9668171	DM	648	650
9668171	DM	879	881
9668171	DM	1165	1167
9668171	DM	1545	1547
9668171	DM	1552	1554
9668171	human genetic diseases	661	683
9671401	retinoblastoma	45	59
9671401	retinoblastoma	282	296
9671401	tumor phenotype	105	120
9671401	tumors	365	371
9671401	tumors	800	806
9674903	Maternal uniparental disomy (UPD)	137	170
9674903	Prader-Willi syndrome (PWS)	237	264
9674903	PWS	260	263
9674903	PWS	320	323
9674903	PWS	534	537
9674903	PWS	864	867
9674903	PWS	961	964
9674903	PWS	1722	1725
9674903	PWS	1838	1841
9674903	Prader-Willi syndrome	20	41
9674903	Prader-Willi syndrome	237	258
9674906	Schwartz-Jampel syndrome type 2	0	31
9674906	Stuve-Wiedemann syndrome	36	60
9674906	Stuve-Wiedemann syndrome	335	359
9674906	Schwartz-Jampel syndrome (SJS)	180	210
9674906	SJS type 2	263	273
9674906	SJS type 2	621	631
9674906	SJS type 2	1251	1261
9674906	SJS type 2	1373	1383
9674906	Stuve-Wiedemann syndrome (SWS)	335	365
9674906	campomelia	383	393
9674906	skeletal dysplasia	227	245
9674906	skeletal dysplasia	408	426
9674906	skeletal dysplasia	986	1004
9674906	contractures	428	440
9674906	contractures	838	850
9674906	prenatal-onset neuromuscular disorder	777	814
9674906	congenital joint contractures	821	850
9674906	respiratory difficulties	-1	-1
9674906	feeding difficulties	868	888
9674906	tendency to hyperthermia	890	914
9674906	frequent death in infancy	920	945
9674906	campomelic-metaphyseal skeletal dysplasia	963	1004
9674906	progressive bone dysplasia	1194	1220
9674906	SWS	361	364
9674906	SWS	665	668
9674906	SWS	736	739
9674906	SWS	1272	1275
9674906	SWS	1365	1368
9689113	von Willebrand disease	24	46
9689113	von Willebrand disease	139	161
9689113	von Willebrand disease	1085	1107
9689113	von Willebrand factor (vWf) deficiency	86	124
9689113	severe von Willebrand disease	17	46
9689113	severe von Willebrand disease	132	161
9689113	vWf-deficient	242	255
9689113	defects in hemostasis	48	69
9689113	defects in hemostasis	496	517
9689113	highly prolonged bleeding time	525	555
9689113	spontaneous bleeding events	560	587
9689113	factor VIII level reduced	-1	-1
9689113	defective thrombosis	-1	-1
9689113	severe human von Willebrand disease	1072	1107
9700175	hereditary ovarian cancer	36	61
9700175	hereditary ovarian cancer	416	441
9700175	ovarian cancer	47	61
9700175	ovarian cancer	211	225
9700175	ovarian cancer	263	277
9700175	ovarian cancer	364	378
9700175	ovarian cancer	427	441
9700175	ovarian cancer	925	939
9700175	ovarian cancer	1244	1258
9700175	ovarian cancer	1528	1542
9700175	hereditary forms of ovarian cancer	344	378
9700175	BRCA1	158	163
9700175	BRCA1	561	566
9700175	BRCA1	1284	1289
9700175	BRCA1	1585	1590
9700175	BRCA2	171	176
9700175	BRCA2	582	587
9700175	BRCA2	1388	1393
9700175	BRCA2	1594	1599
9700175	BRCA1 mutation	1284	1298
9700175	BRCA2 mutation	1388	1402
9702690	adrenoleukodystrophy	23	43
9702690	adrenoleukodystrophy	163	183
9702690	adrenoleukodystrophy (ALD)	163	189
9702690	ALD	185	188
9702690	ALD	242	245
9702690	ALD	511	514
9702690	ALD	1194	1197
9702690	ALD	1407	1410
9702690	ALD	1703	1706
9702690	adult cerebral and cerebello-brain stem forms	393	438
9702690	childhood ALD	501	514
9702690	childhood ALD	1184	1197
9702690	adolescent form	589	604
9702690	Alzheimers disease (AD)	703	726
9702690	AD	723	725
9702690	abnormalities in the bilateral cerebellar hemispheres and brain stem	776	844
9702690	massive demyelination of the cerebral white matter	1071	1121
9702690	neuronal degeneration	1678	1699
9702690	insidious lesion	1539	1555
9703418	complement C9 deficiency	87	111
9703418	complement deficiency	191	212
9703418	C9 deficiency	98	111
9703418	C9 deficiency	288	301
9703418	C9 deficiency	882	895
9703418	meningococcal meningitis	363	387
9703418	C9-deficient	319	331
9703418	C9-deficient	517	529
9703501	breast cancer	-1	-1
9703501	ovarian cancer	88	102
9703501	oxidative DNA damage	51	71
9703501	oxidative DNA damage	556	576
9703501	oxidative DNA damage	752	772
9703501	transcription-coupled repair of oxidative DNA damage	19	71
9703501	transcription-coupled repair of oxidative DNA damage	524	576
9703501	transcription-coupled repair of oxidative DNA damage	720	772
9703501	hypersensitive to ionizing radiation	586	622
9703501	hypersensitive to hydrogen peroxide	-1	-1
9705283	aniridia	425	433
9705283	aniridia	592	600
9705283	aniridia	1524	1532
9705283	Peters anomaly	435	449
9705283	autosomal dominant keratitis	451	479
9705283	familial foveal dysplasia	485	510
9705283	Aniridia	757	765
9709714	severe hypertrophic cardiomyopathy	12	46
9709714	severe hypertrophic cardiomyopathy	424	458
9709714	very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency	-1	-1
9709714	VLCAD deficiency	364	380
9709714	VLCAD deficiency	535	551
9709714	VLCAD deficiency	1061	1077
9709714	hypertrophic cardiomyopathy	19	46
9709714	hypertrophic cardiomyopathy	431	458
9709714	hepatomegaly	460	472
9709714	encephalopathy	474	488
9709714	hypotonia	494	503
9714764	insulin-dependent diabetes mellitus (IDDM)	171	213
9714764	diabetes	189	197
9714764	diabetes	340	348
9729124	congenital chloride diarrhea (CLD)	31	65
9729124	CLD	61	64
9729124	CLD	102	105
9729124	CLD	249	252
9729124	CLD	643	646
9729124	CLD	900	903
9729124	Pendred syndrome	971	987
9731533	familial adenomatous polyposis (FAP)	132	168
9731533	FAP	164	167
9731533	colorectal cancer (CRC)	316	339
9731533	CRC	335	338
9731533	CRC	741	744
9731533	cancer	25	31
9731533	cancer	327	333
9731533	cancer	789	795
9731533	cancer	909	915
9731533	colorectal	316	326
9731533	colorectal	880	890
9731533	breast	892	898
9731533	cancers	909	916
9733027	Friedreich ataxia	24	41
9733027	Friedreich ataxia	124	141
9733027	premutation	42	53
9733027	premutation	305	316
9733027	premutation	385	396
9733027	premutation	908	919
9744473	metachromatic leukodystrophy	53	81
9744473	metachromatic leukodystrophy	143	171
9744473	arylsulfatase A (ARSA) enzyme activity	97	135
9744473	metachromatic leukodystrophy (MLD)	143	177
9744473	MLD	173	176
9744473	MLD	227	230
9744473	MLD	320	323
9744473	MLD	750	753
9770531	von Hippel-Lindau (VHL)	161	184
9770531	renal cell carcinoma	56	76
9770531	renal cell carcinoma	219	239
9770531	renal cell carcinoma	750	770
9770531	human cancers	1172	1185
9770531	cancer	1178	1184
9770531	cancer	1358	1364
9771706	diabetes mellitus	68	85
9771706	diabetes mellitus	265	282
9771706	optic atrophy	90	103
9771706	optic atrophy	299	312
9771706	Wolfram syndrome	105	121
9771706	Wolfram syndrome	124	140
9771706	Wolfram syndrome (WFS; OMIM 222300)	124	159
9771706	neurodegenerative disorder	186	212
9771706	non-immune insulin-dependent diabetes mellitus	236	282
9771706	progressive optic atrophy	287	312
9771706	WFS	142	145
9771706	WFS	458	461
9771706	WFS	548	551
9771706	WFS	642	645
9771706	WFS	720	723
9771706	disease phenotype	701	718
9774970	familial	158	166
9774970	early onset breast cancer	-1	-1
9774970	ovarian cancer	194	208
9774970	ovarian cancer	859	873
9774970	hereditary breast cancer	-1	-1
9774970	hereditary ovarian cancer	-1	-1
9790667	cerebrotendinous xanthomatosis	269	299
9790667	CTX	301	304
9790667	deficiency in the sterol 27-hydroxylase activity	438	486
9790667	deficiency in the sterol 27-hydroxylase activity	1364	1412
9792409	classical ataxia-telangiectasia	26	57
9792409	ataxia-telangiectasia	36	57
9792409	ataxia-telangiectasia	180	201
9792409	A-T	203	206
9792409	A-T	284	287
9792409	A-T	1019	1022
9792409	A-T	1077	1080
9792409	A-T	1526	1529
9792409	classical A-T	274	287
9792409	classical A-T	1516	1529
9792409	Turkish A-T	1011	1022
9792409	Turkish A-T	1069	1080
9792860	autosomal recessive Alport syndrome	89	124
9792860	autosomal recessive Alport syndrome	716	751
9792860	hematuric glomerulonephritis	179	207
9792861	breast cancer	138	151
9792861	breast cancer	210	223
9792861	breast cancer	967	980
9792861	breast cancer	1029	1042
9792861	breast cancer	1453	1466
9792861	ovarian cancer	64	78
9792861	ovarian cancer	235	249
9792861	ovarian cancer	807	821
9792861	ovarian cancer	1478	1492
9792861	breast/ovarian cancer	228	249
9792861	breast/ovarian cancer	1471	1492
9800909	cognitive impairment	56	76
9800909	cognitive impairment	288	308
9800909	cognitive impairment	912	932
9800909	cognitive impairment	1226	1246
9800909	Duchenne muscular dystrophy	80	107
9800909	Duchenne muscular dystrophy	205	232
9800909	DMD	234	237
9800909	DMD	326	329
9800909	DMD	481	484
9800909	DMD	1168	1171
9800909	DMD	1263	1266
9800909	severe cerebral dysfunction	1032	1059
9831355	hereditary non-polyposis colorectal cancer	59	101
9831355	hereditary non-polyposis colorectal cancer	133	175
9831355	HNPCC	177	182
9831355	colorectal cancer	84	101
9831355	colorectal cancer	158	175
9831355	colorectal cancer	325	342
9843038	Hereditary coproporphyria	99	124
9843038	HCP	126	129
9843038	HCP	320	323
9843038	disease	156	163
9843038	deficiency of coproporphyrinogen oxidase (CPO)	183	229
9848786	Human complement factor H deficiency	0	36
9848786	hemolytic uremic syndrome	53	78
9848786	hemolytic uremic syndrome	296	321
9848786	deficiency	26	36
9848786	deficiency	115	125
9848786	deficiency	372	382
9848786	deficiency	638	648
9848786	deficiency	740	750
9848786	deficiency	804	814
9848786	deficiency	900	910
9848786	deficiency	934	944
9848786	acute renal disease	204	223
9848786	idiopathic hemolytic uremic syndrome	285	321
9848786	HUS	323	326
9848786	HUS	961	964
9848786	HUS	1061	1064
9848786	homozygous deficiency	361	382
9848786	homozygous deficiency	627	648
9848786	Factor H deficiency	891	910
9848786	complement deficiency	923	944
9848786	idiopathic HUS	1050	1064
9852676	myotonic dystrophy	57	75
9852676	myotonic dystrophy	144	162
9852676	DM	164	166
9852676	DM	306	308
9852676	DM	370	372
9852676	DM	524	526
9852676	DM	718	720
9852676	DM	917	919
9852676	DM	1258	1260
9852676	Friedreichs ataxia	1265	1283
9856498	C6 deficiency	23	36
9856498	C6 deficiency	289	302
9856498	Deficiency of the sixth component of human complement (C6)	72	130
9856498	Meningococcal disease	210	231
9856498	total C6 deficiency	283	302
9856498	C6Q0	304	308
9856498	C6Q0	1048	1052
9856498	recurrent disease	343	360
9856498	total deficiency	485	501
9856498	C6-deficient	1150	1162
9856499	Complement C7 deficiency	0	24
9856499	C7 deficiency	11	24
9856499	C7 deficiency	131	144
9856499	C7 defects	487	497
9861003	bipolar affective disorder	105	131
9861003	Bipolar affective disorder (BPAD; manic-depressive illness)	159	218
9861003	BPAD	187	191
9861003	BPAD	409	413
9861003	BPAD	544	548
9861003	BPAD	651	655
9861003	BPAD	932	936
9861003	BPAD	1484	1488
9861003	mental health wellness	52	74
9861003	mental health wellness	721	743
9861003	mental health wellness	1334	1356
9861003	psychiatric disorder	760	780
9861003	affective disorders	1515	1534
9863607	myotonic dystrophy	26	44
9863607	myotonic dystrophy	225	243
9863607	Myotonic dystrophy (DM)	46	69
9863607	infertility	198	209
9863607	congenital myotonic dystrophy (CDM)	214	249
9863607	DM	66	68
9863607	DM	246	248
9863607	DM	276	278
9863607	DM	405	407
9863607	DM	476	478
9863607	DM	513	515
9863607	DM	684	686
9863607	DM	917	919
9863607	DM	982	984
9863607	DM	998	1000
9863607	DM	1071	1073
9867744	hemochromatosis	13	28
9867744	hemochromatosis	44	59
9867744	hemochromatosis	682	697
9867744	hemochromatosis	793	808
9867744	hemochromatosis	904	919
9867744	disease	111	118
9867744	disease	869	876
9867744	disease	1007	1014
9867744	iron overload	452	465
9867744	cirrhosis	533	542
9867744	cirrhosis	935	944
9867744	hepatic cirrhosis	927	944
9867744	chronic disease	999	1014
9869602	colorectal cancer	98	115
9869602	colorectal cancer	204	221
9869602	colorectal cancer	348	365
9869602	colorectal cancer	484	501
9869602	colorectal cancer	777	794
9869602	colorectal cancer	1381	1398
9869602	neoplasia	636	645
9869602	neoplasia	1048	1057
9869602	neoplasia	1198	1207
9869602	familial cancer	938	953
9869602	colorectal neoplasia	-1	-1
9869602	noncolonic neoplasia	1187	1207
9888388	hereditary coproporphyria	66	91
9888388	Hereditary coproporphyria (HC)	113	143
9888388	acute hepatic porphyria	150	173
9888388	neurological dysfunction	357	381
9888388	infectious diseases	450	469
9888388	Skin photosensitivity	471	492
9888388	HC	140	142
9888388	HC	773	775
9888388	HC	1886	1888
9888390	metachromatic leukodystrophy	92	120
9888390	metachromatic leukodystrophy	239	267
9888390	classical late infantile metachromatic leukodystrophy (MLD)	214	273
9888390	MLD	269	272
9888390	MLD	572	575
9888390	MLD	1289	1292
9888390	MLD	1440	1443
9888390	MLD	1557	1560
9888390	MLD-like	1557	1565
9888390	disease	1620	1627
9888390	disease	1880	1887
9927033	Human MLH1 deficiency	0	21
9927033	hematological malignancy	37	61
9927033	hematological malignancy	415	439
9927033	neurofibromatosis type 1	66	90
9927033	neurofibromatosis type 1	505	529
9927033	neurofibromatosis type 1	843	867
9927033	hereditary nonpolyposis colorectal cancer	166	207
9927033	hereditary nonpolyposis colorectal cancer	352	393
9927033	neurofibromatosis type 1 (NF1)	505	535
9927033	MLH1 mutation	631	644
9927033	MLH1 mutation	698	711
9927033	mismatch repair deficiency	727	753
9927033	leukemia	802	810
9927033	lymphoma	818	826
9931324	aniridia (congenital absence of the iris)	175	216
9931324	aniridia	175	183
9931324	aniridia	293	301
9931324	aniridia	742	750
9931324	aniridia	976	984
9931324	aniridia	1208	1216
9931324	missense mutations	657	675
9931324	missense mutations	899	917
9931324	missense mutations	1018	1036
9931324	missense mutations	1457	1475
9931324	aniridia patients	293	310
9931324	aniridia patients	742	759
9931324	atypical phenotypes	1062	1081
9931324	ectopia pupillae (displaced pupils)	1083	1118
9931324	congenital nystagmus (searching gaze)	1123	1160
9931324	aniridia phenotypes	1208	1227
9931324	PAX6 -related disease	1549	1570
9949197	Emery-Dreifuss muscular dystrophy	68	101
9949197	Emery-Dreifuss muscular dystrophy	173	206
9949197	Emery-Dreifuss muscular dystrophy (EDMD)	173	213
9949197	cardiac defects in EDMD	1146	1169
9949197	EDMD	208	212
9949197	EDMD	1165	1169
9949197	EDMD	1456	1460
9949197	EDMD	1685	1689
9949209	copper toxicosis	23	39
9949209	copper toxicosis	637	653
9949209	inherited disorder	206	224
9949209	hepatic copper accumulation	158	185
9949209	hepatic copper accumulation	272	299
9949209	Wilson disease (WD)	346	365
9949209	ATP7B genes	384	395
9949209	human copper overload disease	493	522
9949209	non-Indian childhood cirrhosis	523	553
9949209	copper toxicosis (CT)	637	658
9949209	progressive liver disease	726	751
9950360	colorectal cancer	155	172
9950360	colorectal cancer	225	242
9950360	colorectal cancer	642	659
9950360	colorectal cancer	732	749
9950360	colorectal cancer	1069	1086
9950360	colorectal cancer	1658	1675
9950360	familial adenomatous polyposis (FAP)	298	334
9950360	adenomatous polyposis coli (APC) gene mutations	380	427
9950360	FAP	96	99
9950360	FAP	330	333
9950360	FAP	638	641
9950360	FAP	713	716
9950360	FAP	728	731
9950360	FAP	943	946
9950360	FAP	1056	1059
9950360	FAP	1220	1223
9950360	FAP	1642	1645
9950360	FAP	1654	1657
9950360	extracolonic manifestations	267	294
9950360	extracolonic manifestations	553	580
9950360	extracolonic manifestations	1189	1216
9950360	non-FAP colorectal cancer	634	659
9950360	non-FAP colorectal cancer	724	749
9950360	non-FAP colorectal cancer	1650	1675
9973276	Inherited colorectal polyposis	0	30
9973276	colorectal tumor formation	162	188
9973276	familial adenomatous polyposis syndrome	192	231
9973276	sporadic colorectal carcinogenesis	236	270
9973276	APC I1307K polymorphism	54	77
9973276	APC I1307K polymorphism	654	677
9973276	adenomatous polyps	600	618
9973276	colorectal cancer	627	644
9973276	colorectal cancer	1039	1056
9973276	colorectal cancer	1256	1273
9973276	colorectal cancer	1507	1524
9973276	colorectal neoplasia	904	924
9973276	adenomas	1026	1034
9973276	colorectal cancers	1039	1057
9988281	BRCA1 tumour-suppressor gene	119	147
9988281	hereditary breast and ovarian cancer	152	188
9988281	BRCA1 mutations	268	283
9988281	sporadic cancers	296	312
9988281	non-familial breast and ovarian cancers	437	476
9988281	breast malignancies	996	1015
9988281	benign breast	1108	1121
9988281	invasive lobular cancers	1123	1147
9988281	low-grade ductal carcinomas	1152	1179
9988281	high-grade	44	54
9988281	high-grade	1257	1267
9988281	sporadic breast cancers	1387	1410
